Company Filing History:
Years Active: 2023-2024
Title: Emma Elizabeth Baston: Innovator in Immunotherapy
Introduction
Emma Elizabeth Baston is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of immunotherapy, particularly in the development of T cell receptors for the treatment of diseases such as HIV and cancer. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
Emma's latest patents include groundbreaking advancements in HIV-specific binding molecules. These specific binding molecules, including T cell receptors (TCRs), are designed to bind the HLA-A*02 restricted peptide SLYNTVATL derived from the HIV Gag gene product, p17. The TCRs feature non-natural mutations within the alpha and/or beta variable domains, enhancing their stability and yield while retaining advantageous properties. This innovation is particularly useful in developing soluble immunotherapeutic reagents for treating HIV-infected individuals.
Another notable patent involves T cell receptors specific for the NY-ESO-1 tumor antigen-HLA-A*02 complex. These TCRs bind the HLA-A*02 restricted peptide SLLMWITQC derived from the cancer antigen NY-ESO-1. The TCRs may also include mutations within the alpha and/or beta variable domains, making them suitable for use as novel immunotherapeutic reagents in treating malignant diseases.
Career Highlights
Emma is currently associated with Immunocore Limited, a company known for its innovative approaches in immunotherapy. Her work has significantly impacted the development of treatments for serious health conditions, showcasing her expertise and dedication to advancing medical science.
Collaborations
Emma collaborates with talented individuals in her field, including Marcin Dembek and Luis Filipe Da Silva Godinho. These partnerships enhance the research and development of new therapeutic solutions.
Conclusion
Emma Elizabeth Baston is a trailblazer in the field of immunotherapy, with her patents reflecting her commitment to improving treatment options for patients. Her innovative work continues to inspire advancements in medical research and therapy.